Function and survival of macroencapsulated syngeneic islets transplanted into streptozocin-diabetic mice

Transplantation

Volumn 66, Issue 1, 1998, Pages 21-28

  Suzuki, Kazuhisa ^a   Bonner Weir, Susan ^a   Trivedi, Nitin ^a   Yoon, Kun Ho ^a   Hollister Lock, Jennifer ^a   Colton, Clark K ^b   Weir, Gordon C ^a,c  

^a HARVARD MEDICAL SCHOOL   (United States)

^b Massachusetts Institute of Technology Cambridge   (United States)

^c JOSLIN DIABETES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; DIABETES MELLITUS; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE TEST; GRAFT REJECTION; GRAFT SURVIVAL; HYPOGLYCEMIA; INSULIN RELEASE; MALE; MOUSE; NONHUMAN; PANCREAS ISLET TRANSPLANTATION; PRIORITY JOURNAL; STREPTOZOCIN DIABETES;

EID: 0032528016     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199807150-00004     Document Type: Article

References (29)

1. Colton CK, Avgoustiniatos ES. Bioengineering in development of the hybrid artificial pancreas. J Biomech Eng 1991; 113: 152.
2. Colton CK. Implantable biohybrid artificial organs. Cell Transplantation 1995; 4: 415.
3. Sun Y, Ma X, Zhou D, Vacek I, Sun AM. Normalization of diabetes in spontaneously diabetic cynomolgus monkeys by xenografts of microencapsulated porcine islets without immunosuppression. J Clin Invest 1996; 98: 1417.
4. Lanza RP, Borland KM, Staruk JE, Appel MC, Solomon BA, Chick WL. Transplantation of encapsulated canine islets into spontaneously diabetic BB/Wor rats without immunosuppression. Endocrinology 1992; 131: 637.
5. Lanza RP, Beyer AM, Staruk JE, Chick WL. Biohybrid artificial pancreas: long-term function of discordant islet xenografts in streptozotocin diabetic rats. Transplantation 1993; 56: 1067.
6. Altman JJ, Penfornis A, Boillot J, Maletti M. Bioartificial pancreas in autoimmune nonobese diabetic mice. ASAIO Transactions 1988; 34: 247.
7. Scharp DW, Swanson CJ, Olack BJ, et al. Protection of encapsulated human islets implanted without immunosuppression in patients with type I or type II diabetes and in nondiabetic control subjects. Diabetes 1994; 43: 1167.
8. Lacy PE, Hegre OD, Gerasimidi-Vazeou A, Gentile FT, Dionne KE. Maintenance of normoglycemia in diabetic mice by subcutaneous xenografts of encapsulated islets. Science 1991; 254: 1782.
9. Lanza RP, Borland KM, Lodge P, et al. Treatment of severely diabetic pancreatectomized dogs using a diffusion-based hybrid pancreas. Diabetes 1992; 41: 886.
10. Brauker J, Martinson LA, Loudovaris T, et al. Immuno-isolation with large pore membranes: allografts are protected under conditions that result in destruction of xenografts. Cell Transplantation 1992; 1: 16.
11. Hill RS, Young SK, Jacobs SA, Martinson LA, Johnson RC. Membrane encapsulated islets implanted in epididymal fat pads corrects diabetes in rats. Cell Transplantation 1992; 1: 168.
12. Andersson A, Eizrik DL, Bremer C, Johnson RC, Pipeleers DG, Hellerstrom C. Structure and function of macroencapsulated human and rodent pancreatic islets transplanted into nude mice. Horm Metab Res 1997; 28: 306.
13. Suzuki K, Bonner-Weir S, Hollister J, Weir GC. A method for estimating number and mass of islets transplanted within a membrane device. Cell Transplantation 1996; 5: 613.
14. Suzuki K, Bonner-Weir S, Hollister J, Colton CK, Weir GC. Number and volume of islets transplanted in immunobarrier devices. Cell Transplantation 1998; 7: 47.
15. Gotoh M, Maki T, Kiyoizumi T, Satomi S, Monaco AP. An improved method for isolation of mouse pancreatic islets. Transplantation 1985; 40: 437.
16. Brauker J, Martinson LA, Young SK, Johnson RC. Local inflammatory response around diffusion chambers containing xenografts. Transplantation 1996; 61: 1671.
17. Brauker JH, Carr-Brendel VE, Martinson LA, Crudele J, Johnston WD, Johnson RC. Neovascularization of synthetic membranes directed by membrane microarchitecture. J Biomed Mater Res 1995; 29: 1517.
18. Padera RF, Colton CK. Time course of membrane microarchitecture-driven neovascularization. Biomaterials 1996; 17: 277.
19. Albano JDM, Ekins RP, Maritz G, Turner RC. A sensitive, precise radioimmunoassay of serum insulin relying on charcoal separation of bound and free hormone moieties. Acta Endocrinologica 1972; 70: 487.
20. Montana E, Bonner-Weir S, Weir GC. Beta cell mass and growth after syngeneic islet cell transplantation in normal and streptozocin-diabetic C57BL/6 mice. J Clin Invest 1993; 91: 780.
21. Montana E, Bonner-Weir S, Weir GC. Transplanted beta cell response to increased metabolic demand. J Clin Invest 1994; 93: 1577.
22. Weir GC, Bonner-Weir S, Leahy JL. Islet mass and function in diabetes and transplantation. Diabetes 1990; 39: 401.
23. Klagsbrun M, D'Amore PA. Regulators of angiogenesis. Annu Rev Physiol 1991; 53: 217.
24. Hanahan D. Signaling vascular morphogenesis and maintenance. Science 1997; 277: 48.
25. Davalli AM, Scaglia L, Zangen DH, Hollister J, Bonner-Weir S, Weir GC. Islet vulnerability in the immediate post-transplant period: role exerted by the recipients metabolic control. Diabetes 1996; 45: 1161.
26. Juang J-H, Bonner-Weir S, Wu Y-J, Weir GC. Beneficial influence of glycemic control upon the growth and function of transplanted islets. Diabetes 1994; 43: 1334.
27. Weir GC, Sharma A, Zangen DH, Bonner-Weir S. Transcription factor abnormalities as a cause of beta cell dysfunction in diabetes: a hypothesis. Acta Diabetologica 1997; 34: 177.
28. Davalli AM, Ogawa Y, Scaglia L, et al. Function, mass, and replication of porcine and rat islets transplanted into diabetic nude mice. Diabetes 1995; 44: 104.
29. Weir GC, Bonner-Weir S. Islets of Langerhans: the puzzle of intraislet interactions and their relevance to diabetes [Perspective]. J Clin Invest 1990; 85: 983.